Photocure ASA (OSL:PHO)

Norway flag Norway · Delayed Price · Currency is NOK
61.90
+0.60 (0.98%)
Aug 15, 2025, 4:25 PM CET
27.10%
Market Cap 1.65B
Revenue (ttm) 522.86M
Net Income (ttm) -5.33M
Shares Out 26.61M
EPS (ttm) -0.20
PE Ratio n/a
Forward PE 133.84
Dividend n/a
Ex-Dividend Date n/a
Volume 22,584
Average Volume 68,713
Open 61.90
Previous Close 61.30
Day's Range 61.00 - 62.40
52-Week Range 47.20 - 71.80
Beta 0.57
RSI 53.77
Earnings Date Jul 30, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen... [Read more]

Sector Healthcare
Founded 1993
Employees 101
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.